MERSANA THERAPEUTICS INC's ticker is MRSN and the CUSIP is 59045L106. A total of 129 filers reported holding MERSANA THERAPEUTICS INC in Q1 2022. The put-call ratio across all filers is 4.48 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $5 | +25.0% | 30,000 | +2400.0% | 0.00% | – |
| Q1 2023 | $4 | -42.9% | 1,200 | 0.0% | 0.00% | -100.0% |
| Q4 2022 | $7 | -99.9% | 1,200 | 0.0% | 0.00% | 0.0% |
| Q3 2022 | $8,000 | +60.0% | 1,200 | -7.7% | 0.00% | – |
| Q2 2022 | $5,000 | +25.0% | 1,300 | 0.0% | 0.00% | – |
| Q1 2022 | $4,000 | -42.9% | 1,300 | +8.3% | 0.00% | – |
| Q4 2021 | $7,000 | -36.4% | 1,200 | 0.0% | 0.00% | – |
| Q3 2021 | $11,000 | -91.9% | 1,200 | -90.2% | 0.00% | -100.0% |
| Q2 2021 | $135,000 | +27.4% | 12,200 | +19.6% | 0.01% | +40.0% |
| Q1 2021 | $106,000 | +307.7% | 10,200 | -50.7% | 0.01% | +400.0% |
| Q4 2020 | $26,000 | +13.0% | 20,700 | +404.9% | 0.00% | 0.0% |
| Q3 2020 | $23,000 | -52.1% | 4,100 | -72.1% | 0.00% | -66.7% |
| Q2 2020 | $48,000 | +4700.0% | 14,700 | +7250.0% | 0.00% | – |
| Q1 2020 | $1,000 | – | 200 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| SILVERARC CAPITAL MANAGEMENT, LLC | 5,000,000 | $6,350,000 | 1.92% |
| VR Adviser, LLC | 11,328,000 | $14,386,560 | 1.51% |
| Bain Capital Life Sciences Investors, LLC | 8,663,673 | $11,002,865 | 1.23% |
| Affinity Asset Advisors, LLC | 2,850,000 | $3,619,500 | 1.02% |
| EcoR1 Capital, LLC | 19,364,688 | $24,593,154 | 0.83% |
| Altium Capital Management LP | 1,059,136 | $1,345,103 | 0.70% |
| 5AM Venture Management, LLC | 1,305,000 | $1,657,350 | 0.48% |
| Decheng Capital Management III (Cayman), LLC | 904,268 | $1,148,420 | 0.38% |
| COMMODORE CAPITAL LP | 2,244,378 | $2,850,360 | 0.33% |
| Philosophy Capital Management LLC | 2,342,634 | $2,975,145 | 0.32% |